research is focused on elucidating the mechanism(s) underlying antibody mediated rejection caused by HLA and non-HLA antibodies and developing non-invasive immune monitoring assays using gene or protein expression patterns as biomarkers to measure the patient?s immune status, to optimize the immunosuppressive therapy and identify transplant recipients at risk of acute and chronic rejection to improve outcomes.